Navigation

Buminate

  • Generic Name: albumin human, usp, 25% solution
  • Brand Name: Buminate 25%

Buminate 25%(Albumin Human, USP, 25% Solution) side effects drug center

PROFESSIONAL

CONSUMER

SIDE EFFECTS

Buminate Side Effects Center

Buminate [albumin (Human)] 25% injection is albumin, the protein portion of the blood, used to treat shock, burns, or low blood protein. Buminate is available in generic form. Side effects of Buminate are rare but may include:

Buminate 25% is administered by IV injection. The dosage depends on the condition being treated. Buminate 25% may interact with other drugs. Tell your doctor all medications and supplements you take. During pregnancy, Buminate 25% should be given only if clearly needed. It is not known whether Buminate 25% passes into breast milk. Consult your doctor before breastfeeding.

Our Buminate 25% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Buminate Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; cough, difficult breathing; swelling of your face, lips, tongue, or throat.

Tell your caregiver right away if you have:

  • a light-headed feeling, like you might pass out;
  • weak or shallow breathing;
  • throbbing headache, blurred vision, buzzing in your ears;
  • anxiety, confusion, sweating, pale skin; or
  • severe shortness of breath, wheezing, gasping for breath, cough with foamy mucus, chest pain, and fast or uneven heart rate.

Common side effects may include:

  • nausea, vomiting;
  • fever, chills;
  • fast heart rate;
  • mild rash; or
  • flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Buminate (Albumin Human, USP, 25% Solution)

 

Buminate Professional Information

SIDE EFFECTS

Adverse Reactions From Clinical Trials

There are no data available on adverse reactions from Baxalta-sponsored clinical trials conducted with BUMINATE 25%.

Post-Marketing Adverse Reactions

The following adverse reactions have been reported in the post-marketing experience.

Immune System Disorders : Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions

Nervous System Disorders : Headache, dysgeusia

Cardiac Disorders : Myocardial infarction, atrial fibrillation, tachycardia

Vascular Disorders : Hypotension, flushing

Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, dyspnea

Gastrointestinal Disorders : Vomiting, nausea

Skin and Subcutaneous Tissue Disorders : Urticaria, rash, pruritus

General Disorders and Administration Site Conditions : Pyrexia, chills

Read the entire FDA prescribing information for Buminate (Albumin Human, USP, 25% Solution)

© Buminate Patient Information is supplied by Cerner Multum, Inc. and Buminate Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.